Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review

• Published in: Case reports in oncological medicine Vol. 2020; no. 2020; pp. 1 - 9
• Main Authors: Vasekar, Monali, Abusharar, Shady Piedra, Moku, Prashanth, Polimera, Hyma, Chintanaboina, JayaKrishna
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 2020; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Abdomen; Age; Bone cancer; Cancer therapies; Care and treatment; Case Report; Case reports; Chemotherapy; Ewings sarcoma; Literature reviews; Lungs; Lymphatic system; Medical prognosis; Metastasis; Pancreas; Patients; Radiation therapy; Sarcoma; Tumors; Vincristine
• ISSN: 2090-6706; 2090-6714
• DOI: 10.1155/2020/7075048

Ewing sarcoma (ES) is a highly aggressive malignant bone cancer. ES is part of the Ewing sarcoma family of tumors (ESFT), which express characteristic t(11;22) translocation as well as higher levels of CD99. Given that metastasis and tumor burden are significant prognostic factors in patient’s response to treatment, prompt diagnosis is needed to effectively treat ESFT patients. However, the challenges in classifying and characterizing ESFT complicate effective management and treatment of ES. In this report, we present a rare case of ES metastasis to the pancreas. Upon review of the literature, we found 39 cases of ESFT involving the pancreas, but only 3 were metastatic to the pancreas while the remaining cases of ESFT primarily originated from the pancreas. Given the rarity of such metastasis, the positive outcome in our patient’s case may explain the importance of prompt diagnosis in order to initiate appropriate treatment.